IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma.

作者: Donatella Aldinucci , Barbara Rapana’ , Karin Olivo , Debora Lorenzon , Annunziata Gloghini

DOI: 10.1111/J.1365-2141.2009.07945.X

关键词:

摘要: The effects of proliferative, apoptotic and anti-proliferative stimuli on interferon regulatory factor 4 (IRF4) expression by Reed-Sternberg (RS) cells were analysed using a panel Hodgkin lymphoma (HL)-derived cell lines. IRF4 expressed HL was consistently upregulated after CD40 engagement; downregulated agonistic anti-CD95 antibodies in the FAS-sensitive HDLM-2 treatment with Adriamycin Dacarbazine, two chemotherapic agents commonly used for treatment. These results demonstrated, first time, that up-modulated engagement, down-modulated signals, suggesting an involvement also pathobiology.

参考文章(15)
Lingjun Zhao, Luis Del Valle, Judith Miklossy, Luwen Zhang, Dongsheng Xu, Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes Journal of Virology. ,vol. 82, pp. 6251- 6258 ,(2008) , 10.1128/JVI.00163-08
Brian F. Skinnider, Tak W. Mak, The role of cytokines in classical Hodgkin lymphoma Blood. ,vol. 99, pp. 4283- 4297 ,(2002) , 10.1182/BLOOD-2002-01-0099
Ralf Küppers, The biology of Hodgkin's lymphoma Nature Reviews Cancer. ,vol. 9, pp. 15- 27 ,(2009) , 10.1038/NRC2542
Lara Cattaruzza, Antonio Pinto, Annunziata Gloghini, Antonino Carbone, Alfonso Colombatti, Donatella Aldinucci, Debora Lorenzon, Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. International Journal of Cancer. ,vol. 122, pp. 769- 776 ,(2008) , 10.1002/IJC.23119
Daniel Re, Andreas Hofmann, Jürgen Wolf, Volker Diehl, Andrea Staratschek-Jox, Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95. Experimental Hematology. ,vol. 28, pp. 31- 35 ,(2000) , 10.1016/S0301-472X(99)00125-3
Antonino Carbone, Annunziata Gloghini, Donatella Aldinucci, Valter Gattei, Riccardo Dalla-Favera, Gianluca Gaidano, Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease British Journal of Haematology. ,vol. 117, pp. 366- 372 ,(2002) , 10.1046/J.1365-2141.2002.03456.X
Antonino Carbone, Annunziata Gloghini, Luigi M. Larocca, Daniela Capello, Francesco Pierconti, Vincenzo Canzonieri, Umberto Tirelli, Riccardo Dalla-Favera, Gianluca Gaidano, Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus–related lymphomas Blood. ,vol. 97, pp. 744- 751 ,(2001) , 10.1182/BLOOD.V97.3.744
Masumichi Saito, Jie Gao, Katia Basso, Yukiko Kitagawa, Paula M. Smith, Govind Bhagat, Alessandra Pernis, Laura Pasqualucci, Riccardo Dalla-Favera, A Signaling Pathway Mediating Downregulation of BCL6 in Germinal Center B Cells Is Blocked by BCL6 Gene Alterations in B Cell Lymphoma Cancer Cell. ,vol. 12, pp. 280- 292 ,(2007) , 10.1016/J.CCR.2007.08.011
Donata Verdelli, Lucia Nobili, Katia Todoerti, Daniela Intini, Maria Cosenza, Monica Civallero, Jessika Bertacchini, Giorgio Lambertenghi Deliliers, Stefano Sacchi, Luigia Lombardi, Antonino Neri, Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression. Hematological Oncology. ,vol. 27, pp. 23- 30 ,(2009) , 10.1002/HON.875
Ulf Klein, Stefano Casola, Giorgio Cattoretti, Qiong Shen, Marie Lia, Tongwei Mo, Thomas Ludwig, Klaus Rajewsky, Riccardo Dalla-Favera, Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nature Immunology. ,vol. 7, pp. 773- 782 ,(2006) , 10.1038/NI1357